Quick Answer
Niagen Bioscience, Inc. reported Gross Profit of $83.19 million for fiscal year 2025.
Niagen Bioscience, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $83.19M | +35.1% |
| 2024 | $61.59M | +21.3% |
| 2023 | $50.78M | +18.7% |
| 2022 | $42.80M | +3.2% |
| 2021 | $41.49M | +17.6% |
| 2020 | $35.27M | +36.9% |
| 2019 | $25.77M | +60.5% |
| 2018 | $16.05M | +53.2% |
| 2017 | $10.48M | +0.8% |
| 2016 | $10.39M | +37.9% |
| 2015 | $7.53M | +41.5% |
| 2014 | $5.33M | +70.0% |
| 2013 | $3.13M | +37.7% |
| 2012 | $2.28M | -7.9% |
| 2011 | $2.47M | -16.1% |
| 2010 | $2.94M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $21.93M | +35.0% | +8.4% |
| June 30, 2025 | $20.23M | +47.7% | +4.6% |
| March 31, 2025 | $19.33M | +43.7% | +19.0% |
| September 30, 2024 | $16.24M | +35.7% | +18.6% |
| June 30, 2024 | $13.69M | +10.8% | +1.8% |
| March 31, 2024 | $13.46M | -0.5% | +12.4% |
| September 30, 2023 | $11.97M | +17.3% | -3.1% |
| June 30, 2023 | $12.36M | +23.0% | -8.6% |
- Niagen Bioscience, Inc. showed an increase of +35.1% in Gross Profit compared to the prior fiscal year.
- Over the 2010–2025 period, Niagen Bioscience, Inc.’s gross profit has grown by 2724.9% (from $2.94 million to $83.19 million).
- The most recent figure is from Niagen Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: